Jun 8, 2022 7:00am EDT Rigel Announces Top-line Results from FORWARD Phase 3 Clinical Trial of Fostamatinib in Patients with Warm Autoimmune Hemolytic Anemia
May 3, 2022 4:01pm EDT Rigel Reports First Quarter 2022 Financial Results and Provides Business Update
